G Model
CCLET-3148; No. of Pages 4
2
Q. Sun et al. / Chinese Chemical Letters xxx (2014) xxx–xxx
(200 mmol) at 0 8C. The reaction was stirred for 2 h and then
warmed up to 22 8C. After 24 h, MnO2 was filtered off and washed
with ethyl acetate (10 mL). The combined filtrate was concentrated
in vacuo. Flash column chromatography on silica gel afforded the
product.
121.5, 122.8, 124.6, 126.0, 127.6, 128.0, 128.5, 129.8, 135.1, 136.3,
138.9, 144.3, 144.7, 154.5, 157.6, 169.8; IR (neat, cmÀ1): 3674,
1622, 1497, 1460, 1395, 1275, 1218, 1067, 809, 754; HRMS (ESI+):
m/z calcd. for C30H30N4S [M+H]+: 479.2191; found: 479.2184.
4-[(E)-2-(5-Benzothiazol-2-yl-1-phenyl-1H-benzoimidazol-2-
(E)-3-N-Cyclohexyl-N-ethylaminoacrolein (4): Yellow solid; mp
yl)ethenyl]morpholine (22): Yellow solid; mp 172–174 8C (decomp.);
58–60 8C; 1H NMR (400 MHz, CDCl3):
d
0.94–1.26 (m, 6H), 1.26–
1H NMR (400 MHz, CDCl3):
d 3.12–3.24 (m, 4H), 3.71 (t, 4H,
1.40 (m, 2H), 1.50–1.61 (m, 1H), 1.74 (d, 4H, J = 10.6 Hz), 2.90–3.19
(m, 3H), 5.06 (dd, 1H, J1 = 8.7 Hz, J2 = 12.5 Hz), 6.98 (d, 1H,
J = 12.8 Hz), 8.92 (d, 1H, J = 8.6 Hz); 13C NMR (100 MHz, CDCl3):
J = 4.6 Hz), 4.95 (d, 1H, J = 13.3 Hz), 7.10 (d, 1H, J = 8.4 Hz), 7.34 (dd,
1H, J1 = J2 = 7.7 Hz), 7.39–7.49 (m, 3H), 7.52 (dd, 1H, J1 = J2 = 7.2 Hz),
7.60 (dd, 2H, J1 = J2 = 7.2 Hz), 7.73 (d, 1H, J = 13.3 Hz), 7.88 (d, 1H,
J = 7.9 Hz), 7.95(d,1H, J = 8.3 Hz), 8.05(d, 1H,J = 8.0 Hz), 8.26(s, 1H);
d
12.3, 25.0, 25.5, 32.3, 42.1, 65.1, 100.9, 156.7, 189.1; IR (neat,
cmÀ1):
nmax 2927, 2848, 1595, 1442, 1350, 1161, 893, 795; HRMS
13C NMR (100 MHz, CDCl3):
d 48.6, 66.3, 83.3, 109.5, 117.2, 120.9,
(ESI+): m/z calcd. for C11H19NO [M+H]+: 182.1467; found:
182.1458.
121.6, 123.0, 124.8, 126.2, 127.7, 128.5, 128.9, 130.1, 135.3, 136.0,
138.9, 144.0, 147.0, 154.6, 156.1, 169.5; IR (neat, cmÀ1): 3674, 1624,
1498, 1443, 1392, 1081, 890, 759; HRMS (ESI+): m/z calcd. for
(E)-3-(4-Methylpiperazin-1-yl)acrylaldehyde (6): Yellow oil; 1H
NMR (400 MHz, CDCl3):
2.74–3.28 (m, 4H), 4.76–4.89 (m, 1H), 6.64–6.78 (m, 1H), 8.65–8.75
(m, 1H); 13C NMR (100 MHz, CDCl3):
44.4, 45.3, 53.5, 100.4, 158.4,
d
1.88–1.99 (m, 3H), 2.00–2.21 (m, 4H),
C
26H22N4OS [M+H]+: 439.1514; found: 439.1506.
4-Methyl-[(E)-2-(5-benzothiazol-2-yl-1-phenyl-1H-benzoimida-
d
zol-2-yl)ethenyl]piperazine (23): Yellow solid; mp 180–182 8C
(decomp.); 1H NMR (400 MHz, CDCl3):
2.29 (s, 3H), 2.40 (t, 4H,
188.6; IR (neat, cmÀ1): nmax 2944, 1597, 1435, 1317, 1173, 767;
HRMS (ESI+): m/z calcd. for C8H14N2O [M+H]+: 155.1106; found:
155.1112.
d
J = 4.7 Hz), 3.19 (t, 4H, J = 4.6 Hz), 4.89 (d, 1H, J = 13.2 Hz), 7.07 (d,
1H, J = 8.4 Hz), 7.33 (dd, 1H, J1 = J2 = 7.7 Hz), 7.37–7.47 (m, 3H),
7.50 (dd, 1H, J1 = J2 = 7.2 Hz), 7.58 (dd, 2H, J1 = J2 = 7.4 Hz), 7.74 (d,
1H, J = 13.2 Hz), 7.87 (d, 1H, J = 7.9 Hz), 7.93 (d, 1H, J = 8.4 Hz), 8.03
2.2. General procedure for the synthesis of 2-aminovinyl
benzimidazoles (13–25)
(d, 1H, J = 8.1 Hz), 8.24 (s, 1H); 13C NMR (100 MHz, CDCl3):
d 46.3,
48.3, 54.4, 82.3, 109.4, 117.0, 120.6, 121.5, 122.9, 124.7, 126.1,
127.6, 128.2, 128.8, 130.0, 135.2, 136.0, 138.8, 144.0, 146.8, 154.5,
156.5, 169.6; IR (neat, cmÀ1): 3680, 1623, 1495, 1408, 1380, 1240,
1056, 899, 751; HRMS (ESI+): m/z calcd. for C27H25N5S [M+H]+:
452.1831; found: 452.1841.
To a solution of 1,2-phenylenediamine (0.1 mmol) and 3-
aminoacrolein (0.12–0.15 mmol) in ethanol (15 mL) was added
Cp2ZrCl2 (0.05 mmol). The solution was subjected to microwave
heating at 80 8C for 3–5 min. Then, MnO2 (0.5 mmol) was added,
and the reaction was stirred for 5 min. MnO2 was filtered off and
washed with ethanol (5 mL). The combined filtrate was concen-
trated in vacuo. Flash column chromatography on silica gel
afforded the product.
4-[(E)-2-Phenyl-1H-benzoimidazole-2-yl)ethenyl]morpholine
(24): Yellow solid; mp 64–66 8C; 1H NMR (400 MHz, CDCl3):
d 3.11
(t, 4H, J = 4.8 Hz), 3.68 (t, 4H, J = 4.8 Hz), 4.97 (d, 1H, J = 13.4 Hz),
7.00–7.09 (m, 2H), 7.19 (dd, 1H, J1 = J2 = 7.6 Hz), 7.39 (d, 2H,
J = 7.2 Hz), 7.48 (dd, 1H, J1 = J2 = 7.3 Hz), 7.56 (dd, 2H,
J1 = J2 = 7.2 Hz), 7.63 (d, 1H, J = 7.6 Hz), 7.66 (d, 1H, J = 13.2 Hz);
[(E)-2-(5-Benzothiazole-2-yl-1-phenyl-1H-benzoimidazole-2-
yl)ethenyl]isopropylphenylamine (19): Yellow solid; mp 172–
174 8C; 1H NMR (400 MHz, CDCl3):
d
1.24 (d, 6H, J = 6.7 Hz), 3.
13C NMR (100 MHz, CDCl3):
d 48.5, 66.3, 84.0, 109.2, 117.5, 121.0,
84–3. 98 (m, 1H), 4.84 (d, 1H, J = 13.3 Hz), 7.08 (d, 1H, J = 8.4 Hz),
7.13 (d, 2H, J = 7.8 Hz), 7.21 (dd, 1H, J1 = J2 = 7.2 Hz), 7.27–7.52 (m,
9H), 7.86 (d, 1H, J = 7.9 Hz), 7.93 (d, 1H, J = 8.4 Hz), 8.00–8.10 (m,
122.4, 127.7, 128.5, 129.8, 136.4, 136.6, 143.6, 146.3, 154.3; IR (neat,
cmÀ1): 3406, 1624, 1585, 1459, 1381, 1254, 1027, 956, 767; HRMS
(ESI+): m/z calcd. forC19H19N3S [M+H]+: 306.1528;found: 306.1519.
{(E)-2-[5-Benzothiazole-2-yl-1-(4-methoxyphenyl)-1H-benzoimi-
dazole-2-yl]ethenyl}methylbenzylamine (25): Yellow solid; mp 76–
2H), 8.27 (s, 1H); 13C NMR (100 MHz, CDCl3):
d 21.8, 54.7, 84.2,
109.3, 117.0, 120.5, 121.5, 122.9, 124.6, 126.1, 126.9, 127.3, 128.0,
128.1, 128.5, 129.3, 129.7, 135.1, 135.9, 138.7, 142.5, 144.1, 145.0,
78 8C; 1H NMR (400 MHz, CDCl3):
d 2.71 (s, 3H), 3.88 (s, 3H), 4.36 (s,
154.5, 156.6, 169.6; IR (neat, cmÀ1):
nmax 3651, 1619, 1586, 1502,
2H), 4.80 (d, 1H, J = 13.0 Hz), 7.04 (d, 3H, J = 8.3 Hz), 7.20 (d, 2H,
J = 7.6 Hz), 7.27–7.36 (m, 6H), 7.45 (dd, 1H, J1 = J2 = 7.3 Hz), 7.87 (d,
1H, J = 7.9 Hz), 7.94 (d, 1H, J = 8.3 Hz), 8.02 (d, 1H, J = 8.0 Hz), 8.04–
8.06 (m, 1H), 8.25 (s, 1H); 13C NMR (100 MHz, CDCl3):
d 29.8, 36.6,
1460, 1412, 1071, 869, 754; HRMS (ESI+): m/z calcd. for C31H26N4S
[M+H]+: 487.1878; found: 487.1869.
[(E)-2-(5-Benzothiazole-2-yl-1-phenyl-1H-benzoimidazole-2-
yl)ethenyl]methylbenzylamine (20): Yellow solid; mp 72–74 8C; 1
H
55.7, 59.5, 81.8, 109.2, 115.1, 116.8, 120.4, 121.5, 122.9, 124.6,
126.1, 127.5, 127.8, 128.0, 128.6, 128.8, 135.2, 136.9, 139.3, 144.1,
147.5, 154.5, 157.1, 159.6, 169.8; IR (neat, cmÀ1): 3046, 1631,
1514, 1467, 1278, 1027, 839, 760; HRMS (ESI+): m/z calcd. for
NMR (400 MHz, CDCl3):
d 2.72 (s, 3H), 4.36 (s, 2H), 4.84 (d, 1H,
J = 13.0 Hz), 7.08 (d, 1H, J = 8.4 Hz), 7.20 (d, 2H, J = 7.2 Hz), 7.27–
7.36 (m, 4H), 7.38–7.51 (m, 4H), 7.52–7. 63 (m, 2H), 7.87 (d, 1H,
J = 7.9 Hz), 7.94 (d, 1H, J = 8.2 Hz), 8.05 (d, 2H, J = 10.6 Hz), 8.27 (s,
C
31H26N4OS [M+H]+: 503.1827; found: 503.1819.
1H); 13C NMR (100 MHz, CDCl3):
d 36.7, 59.5, 81.7, 109.3, 116.9,
120.5, 121.5, 122.9, 124.7, 126.1, 127.5, 127.6, 127.8, 128.2, 128.7,
128.8, 129.9, 135.2, 136.1, 136.9, 139.9, 144.1, 147.7, 154.5, 156.7,
169.7; IR (neat, cmÀ1): 3674, 1626, 1595, 1497, 1466, 1276, 1052,
895, 755; HRMS (ESI+): m/z calcd. for C34H24N4S [M+H]+:
473.1722; found: 473.1716.
3. Results and discussion
To explore the scope of the reaction, a series of N-arylated and
N,N-dialkylated 3-aminoacroleins 1–6 were synthesized via a
modified procedure described in Scheme 1 [13]. Treatment of
1.0 equiv. of propargyl alcohol with 0.5 equiv. of amino compounds
in the presence of 10 equiv. of activated MnO2 afforded 1–6 in 53%–
75% yields. Compared to the dH values of the aldehyde protons of
benzaldehyde (10.02), n-hexyl aldehyde (9.66), and cinnamalde-
[(E)-2-(5-Benzothiazole-2-yl-1-phenyl-1H-benzoimidazole-2-
yl)ethenyl]ethylcyclohexylamine (21): Yellow solid; mp 132–134 8C;
1H NMR (400 MHz, CDCl3):
d 0.98–1.16 (m, 3H), 1.18–1.36 (m, 3H),
1.37–1.52 (m, 2H), 1.58–1.70 (m, 1H), 1.82 (d, 4H, J = 10.8 Hz),
3.03–3.31 (m, 3H), 4.74 (d, 1H, J = 13.1 Hz), 7.05 (d, 1H, J = 8.3 Hz),
7.31 (dd, 1H, J1 = J2 = 7.6 Hz), 7.39–7.50 (m, 4H), 7.56 (dd, 2H,
J1 = J2 = 7.6 Hz), 7.84 (d, 1H, J = 3.4 Hz), 7.87 (s, 1H), 7.90 (d, 1H,
J = 8.4 Hz), 8.03 (d, 1H, J = 8.2 Hz), 8.23 (s, 1H); 13C NMR (100 MHz,
hyde (9.74), the dH value of 3-(N-phenyl-N-methyl)aminoacrolein
(1) was much smaller (9.27), indicating that the electropositivity of
the carbonyl group was remarkably lowered due to the conjuga-
tion of electron-donating aniline moiety. This result explained
why the conventional condensation methods for regular aldehyde
CDCl3): d 13.3, 25.4, 26.0, 32.4, 41.2, 64.1, 79.8, 109.0, 116.5, 120.1,
Please cite this article in press as: Q. Sun, et al., Cp2ZrCl2-catalyzed synthesis of 2-aminovinyl benzimidazoles under microwave